SUMMARY A group of 21 patients with immunoproliferative small intestinal disease (IPSID), 10 with alpha heavy chain paraproteinaemia and 11 without it, were HLA typed. The results were compared with 35 disease controls and 120 normal controls. A significant increase of Awl9 and B12 antigens was noted among the patients compared with the control subjects. The high rate of association of both AW19 and B12 antigens in patients as compared with controls suggests a possible haplotype (AwI9, B12) association with IPSID.
The so-called 'Mediterranean' abdominal lymphoma now referred to as immunoproliferative small intestinal disease (IPSID) (WHO, 1975 ) is a disease of the young with a geographical distribution which shows that the overwhelming majority of cases reported have been of Mediterranean or Middle Eastern origin (Ramot et al., 1965; Eidelman et al., 1966; Rappaport et al., 1972; Shahid et al., 1975; Nasr et al., 1976; Zarrabi and Rosner, 1976 (Ramot et al., 1965; Roge et al., 1970) antigens for the A locus, 15 for the B locus, and 226 HLA A WJ9, B12 in immunoproliferative small intestinal disease five for the C locus were detected on the peripheral blood lymphocytes.
The antisera used were monospecific and mostly of local origin, although well-defined antisera from NIH and some from Eurotransplant were also used. At least three antisera were used for detection of each specificity.
Results
As shown in the Table, groups I and II both exhibited a significant increase in AWl9 from the A-locus compared with control groups III and IV (p < 0-001). The former groups (I and II) also showed an increase in B12 from the B-locus compared with controls III and IV (p < 0 001). A relative increase in B17 in group II patients compared with all other groups was also noted.
The most significant finding, however, was the simultaneous presence of both AWI9 and B12 antigens in patients compared with controls, which is suggestive of a haplotype association
The immediate family members of one patient from group I were also studied ( Figure) . The patient's 11 year old sister, and 54 year old mother shared high risk HLA antigens with her. Both were symptom-free, however, with no alpha-chain protein in their sera. Nevertheless, the patient's sister is still below the usual age of onset (15 to 30 years) and is being followed up.
Discussion
IPSID occurs relatively frequently in the Middle Eastern countries and the Mediterranean basin (Ramot etal., 1965; Eidelman et al., 1966; Rappaport et al., 1972; Shahid et al., 1975; Nasr et al., 1976; Zarrabi et al., 1976) . However, our own studies on over 50 patients diagnosed during the past two years at Taj Pahlavi Cancer Institute, Tehran, have not shown a clustering of cases in any one particular region of the country (Banisadre, 1978 gators, 1976; Roge et al., 1970) . In this regard, a review of the literature revealed two reports of the familial incidence of IPSID. The first one, from Iran (Banihashemi et al., 1973) , described three families with lymphoma in multiple family members. One of the families included a 22 year old girl and her 28 year old brother who developed IPSID within six months of each other, even though they had lived far apart. The second report (Maurer et al., 1976) described four brothers (all children between 2 and 7 years old) who all developed IPSID within a span of seven years. These findings raise the possibility of a genetic predisposition or immune deficiency which may pave the way for mutagenic or oncogenic stimuli in the environment. In one family studied by us two members showed 'high risk' HLA antigens in common with the patient, and these members are being closely followed up.
The importance of association between HLA haplotype and disease has been emphasised before (Terasaki and Mickey, 1975) . Our data and the family study of one of our patients in which the inheritance of AW19, B12 as haplotype was shown are suggestive of a significant association between HLA haplotype AW19, B12, and IPSID. Unfortunately, we still have insufficient data concerning lymphatic malignancies other than IPSID, although this is being collected and the findings will be reported later on. It remains to be established whether our findings are significant in terms of susceptibility to the disease or its course.
